|
|
|
|
|
AM |
PM |
|
Monday |
9.00
– 12.00 |
14.00
– 1700 |
|
Tuesday |
9.00
– 12.00 |
|
|
Wednesday |
9.00
– 12.00 |
14.00
– 1700 |
|
Thursday |
9.00
– 12.00 |
14.00
– 1700 |
|
Friday |
9.00
– 12.00 |
|
APPOINTMENT SYSTEM
1. General clinics
|
Monday
(AM session) |
Mixed
male & female clinic |
|
Monday
(PM session) |
Mixed
male & female clinic |
|
Tuesday
(AM
session) |
Mixed
male & female clinic |
|
Wednesday
(PM
session) |
MALES
ONLY |
|
Thursday
(AM
session) |
Mixed
male & female clinic |
|
Thursday
(PM
session) |
Mixed
male & female clinic |
|
Friday
(AM
session) |
Mixed
male & female clinic |
2. Specialist clinics
|
Monday (PM session)(males &females) |
HIV/AIDS follow up |
|
Tuesday (AM session) |
Colposcopy & Inflammatory smears |
|
Wednesday (AM session) |
Vaginal Discharge Clinic |
|
Thursday (PM
session) |
JOINT vulval clinic with Consultant Dermatologist |
SERVICES PROVIDED BY THE BURE CLINIC
1. Comprehensive screening
and treatment for sexually transmissible infections.
2. Partner notification and provider referral
3. HIV antibody tests with pre and post test counseling
4. Clinical, virological and immunological monitoring of HIV antibody
positive/AIDS patients.
5. Support for HIV positive patients, family and friends
6. Sexual Health Education for patients schools medical and paramedical staff
and other agencies.
7. Comprehensive colposcopy service
8. Vulval Clinic jointly provided with a Consultant Dermatologist
9. Hepatitis B immunization programme for "at risk patients"
10. Provision of inpatient care to HIV/AIDS patients
11. Provision of care to patients admitted with sexually transmitted infections
in other wards in the hospital
12. Collaborative research with other agencies involved in the enhancement of
sexual health
· The department believes that the patients'
confidentiality is of the utmost importance and is assured by the Venereal
Disease Act.
· Morality of the patient will never be questioned and to achieve this a
holistic approach is adopted in treatment with full patient participation.
· The department is run on democratic principles.
· Opinions and suggestions are welcomed and encouraged from both service
providers and patients in adopting best practice
· All staff know they have an important role to play and they are aware of
their responsibilities.
· We assure patients of their rights and encourage a civic discharge of their
responsibilities.
In
this annual report we have concentrated on total new patient attendance.
Table
1(in the annex) shows a breakdown of the annual attendance since the clinic
relocated to its present site in 1991. This increase was in part due to client
responsiveness from our open access service and continuing confidence in the
quality care provided. The appointment of the 4 sessional consultant posts has
created a continuum of high quality consultant-based service.
We
now see all patients within 2 working days of requesting an appointment is
consonance with the recommendations of the Monk's report.
The
sex ratios continue to be skewed towards more female attendance. This is
reassuring as women more acutely feel most of the morbidity associated with
STD’s.
1998/99
was characterized by maintaining specialist clinic services in tandem with
maintaining consultant based mixed clinics.
The
incidence of gonorrhoea increased 4-fold from 1995 to 1996 in the Bure Clinic,
and that increase was sustained in 1997, a deviation from the “Health of the
Nation” targets. The trend continued in 1998 and 1999 respectively. There were
44 cases in 1999, representing an increase of 37.5% over 1998 figures (see
annex)
Chlamydia
trachomatis
also increased 2 fold from 1995 to 1996, and that increase was sustained in 1997
and 1998. Nationally a 12% rise was seen in the incidence of chlamydia. The
increase seen in the Bure Clinic is a function of more case detection in the
district as more women are now screened, prompting referral for contact tracing
and partner notification.
The
increases seen are of concern, as both infections contribute to significant
morbidity and are surrogate markers of unsafe sexual practices.
The
fall in incidence of first attack Herpes
Simplex has been due to the revised method of recording. Only culture
positive cases are recorded after 1995. We have however noted a 14.2% increase
between 1996 and 1997. This rise is still sustained in 1998 with an increase of
10.4%. In 1999 there was an increase of 19% in new cases.
An
initial 18.7 % increase in incidence of first attack genital warts was noted
between 1995 and 1996. The decrease of 8.1% between 1996 and 1997 has been due
to the waiting list that had built up with the decrease in medical staffing
alluded to earlier. In 1998 the reported numbers remain the same. In 1999, there
was an increase of 5% in new cases.
Greater
collaboration continues to be fostered with other departments in the hospital
and agencies providing sexual health related services. All child sex abuse cases
are reviewed jointly with a Consultant Paediatrician. There were two cases of
statutory venereal infection seen in 1998. In 1999 we had only one case of
gonorrheal infection isolated from the eyes of an 8 year-old boy. The source
remains a mystery.
The
Vulval clinic run jointly with a Consultant Dermatologist has now been
discontinued. We have not been able to re-establish the service.
The
Colposcopy Service in the Bure Clinic remains under-utilized, because of reduced
cervical cytology screening undertaken in the clinic.
HIV/AIDS
care continues to be multidisciplinary, and led from the Bure Clinic with full
participation of the other departments and relevant services. The Bure Clinic
was enrolled into the Phase 111b of the Roche (Saquinavir) proteinase inhibitor
trial in August 1996, including the Haemophilia cohort following my
participation in the 11th World AIDS Conference held in Vancouver. In
1998 we participated in the expanded access of the Du Pont (Efavirenz) a
non-nucleoside analogue for the use of patients failing on triple therapy. The
benefit of triple therapy became manifest early in our cohorts with continual
improvement. There has been a substantial reduction in inpatient episodes and
disease progression. For the first time we have seen a sharp decrease in
mortality in our cohort. However this has not been sustained in 1997/98.
Virological failures were manifest despite HAART (highly active antiretroviral
therapy), including side effects of these potent regimes.
In
1999 we were able to procure Phase IV medications, Glaxo-Welcome (Amprenavir
& Abacavir). We enrolled a pregnant mother in RCOG Cohort of AZT use in
pregnancy to reduce maternal reduction. Baby remains uninfected 18 months after
delivery. Disease progression from treatment failure occurred in 2 patient in
this period. We now routinely utilize viral resistance assay and therapeutic
drug level monitoring when necessary.
The
acceptability of HIV antibody testing within the department continues to
increase in momentum, especially for heterosexual males and females. Greater
collaboration continues with the Women and Child directorate in seeking to
minimise fetomaternal transmission by offering opportunistic HIV antibody
testing and providing antiretroviral treatment to those infected. Post exposure
prophylaxis to healthcare workers exposed to HIV infection is led from the
department in collaboration with the Occupational Health department, Accident
& Emergency and Ward 17. The Department of Health guideline for routine
screening for HIV and Hepatitis B in pregnancy will be implemented in the Trust
from April 2000.
1.
Participation in the Roche International
phase 111b open label safety study of Saquinavir (Ro 31-8959; HIV – proteinase
inhibitor) in-patients with proven HIV infection
2.
Audit to evaluate “Health of the Nation” target in control of
gonorrhoea. This has now been published; Harry TC. Are the Health
of the Nation’s targets attainable. Int
J STD AIDS 1998; 9: 185 – 6
3.
Audit of the outcome of inflammatory smears managed
in the Bure Clinic. Accepted for Oral presentation at the British
Colposcopy and Cervical Pathology Meeting, Cheltenham, UK
23rd - 26th April 1998. Harry TC, Cozens C.
Outcome of inflammatory smears in women seen in the Bure Clinic.
Int J STD AIDS 1998; 9: 299-300.
4.
Partner
notification and provider referral differences across the Atlantic. Presented at
the MSSVD Spring meeting in Athens. May 1998
5.
Participation
in Dupont open label safety study of Efavirenz (DMP 89421 Sustiva)
non-nucleoside analogue in patients failing on therapy.
6.
Patient-led
survey evaluating responsiveness of the service. Harry TC. Quality and resource
management in GUM service delivery. Int J
STD AIDS 2000; 11: 751-4.
7.
Audit
on the impact of pre-test HIV counseling upon knowledge about HIV and the
motivation to change behaviour. Presented as a poster at the 4th
International Conference on the Biopsychosocial Aspects of HIV Infection,
Ottawa, Canada 15th -18th July 1999.
8.
Evaluation
of sexual health knowledge of adolescents in a Great Yarmouth High School.
Presented as a poster at the 6th World Congress, Sun City, South
Africa 21st - 24th November 1999.
Other
publications:
Harry
TC. Management of Genital Chlamydia
trachomatis infection.
Harry
TC, Clark SL. Are race and ethnicity in STD analysis still of relevance? Sex
Transm Infect.
1998; 74: 231.
Harry
TC. Sexual ill-health among blacks in the UK. Lancet
1998; 351:1363-4
Harry
TC. Sexually transmitted diseases. Lancet
1998; 352:650
Harry
TC, Snobl H. Website as a tool for patient education in sexually transmitted
diseases.
Harry
TC HIV/AIDS in Zambia. eBMJ 9th August
1999.
Harry
TC. Information Technology for postgraduate education. Br
J Obstet Gynaecol 2000;
107: 144
Harry
TC. Sexual health knowledge of adolescents in a Great Yarmouth High School. Int J STD AIDS 2000; 11:
129-31
Harry
TC, Matthews M, Salvary I. Indinavir use: Associated reversible hair loss and
mood disturbance. Int J STD AIDS 2000;
11: 474-6
In 1998 we had a growth of 5.5%
increase in attendance compared to 1997 and 1996. In 1996 and 1997 there was
only an increase of 2.8 and 2.5% respectively. There was an increase of 3.4%
attendance of new/re-registered patients in 1999 from 2215 to 2290 cases.
What has significantly varied over
the last three years has been the increase in the number of KC60 returns,
reportable diagnoses which, which have increased from 2535 in 1995 to 2941 in
1997, 3103 in 1998 and 3107 in 1999. The relevant aspects are that with increase
in the numbers of patients attending so also, the complexity, diversity and the
STD related problems. These have led to significant increase in the workload of
the medical staff. This in turn has increased the resource and manpower demands
on supporting diagnostic services.
There were 2 cases of syphilis seen
in 1999 in our clinic. They were in
2 men who declared themselves homosexuals. The index had
secondary syphilis with a co-existing peri-anal herpes simplex infection probably acquired in London from an itinerant
partner . The contact had a
primary syphilitic chancre on presentation.
The incidences of gonorrhoea remain
sustained in 1998/99 respectively. There was a four-fold increase from 1995 to
1996 in the Bure Clinic (see annex). The national goal was to reduce the
incidence of gonorrhoea among men and women aged 15 - 64 by at least 20% in 1995
(from 61 new cases per 100,000 population in 1990 to no more than 49 new cases
per 100,000 in 1995). There were 31 cases of gonorrhoea seen in Great Yarmouth
& Waveney in 1990. Against a total local population of men and women aged
15- 64 of 122,007, this translates into 25 per 100,000. This level of prevalence
is still maintained in Great Yarmouth & Waveney. In 1999 there were 51 cases
of gonorrhoea including epidemiological treatment, the greatest rise seen in the
district. There were 44 cases of gonorrhoea confirmed by culture. Great Yarmouth
has the highest incidence of teenage pregnancy in the region, a surrogate marker
for unsafe sex.
In east Norfolk, Great Yarmouth has
the highest unemployment rate and deprivation index which is manifested in the
sexual ill health markers of high teenage pregnancy and gonorrheal infections.
The outcome targets of the
Association of Genitourinary Medicine Physicians goals and indicators for the
management of sexually transmitted diseases guidelines for purchasers of
services is to reduce uncomplicated chlamydial infection from GUM Clinics to 100
cases per 100,000 of the population aged 15 - 64 years in 3 years. We have seen
a changing paradigm in the incidence of chlamydia over the last 3 years. The
prevalence has increased from 3.6% in 1995, 6.8% in 1996 to 8.4% in 1997. In
1995 there were 75 cases per 100,000. This increased to 149 per 100,000 in 1997.
In 1998 a slight decrease was seen which is not of any statistical significance.
In 1999 this has increased to 160 cases. This is of concern as during the same
period we have seen an increase in the incidence of gonorrhoea.
This is one of the reasons we have
launched our website, to supplement sexual health education among adolescents in
our catchment population, as 30% of all cases of chlamydia in our district is
amongst those aged under 20.
Between 1995 and 1996 an in increase
of 18.8% of first attack genital warts was noted. The subsequent fall of 8.8%
noted between 1996 and 1997 has been due to implementation of a waiting list
scenario and reduced clinical prioritization of this patient group due to
shortage of medical manpower. In 1999 there was a 4% rise noted in new diagnosed
cases. From 205 cases in 1998 to 209 cases in 1999.
The apparent fall in incidence of
first attack herpes simplex has been due to a revised method of recording this
data after 1995. Only culture positive cases were required to be recorded.
Genuine interpretation of this data indicates a 14.2% increase between 1996 and
1997. Viral typing was introduced in April 1997. In 1998, we had 53 cases. In
1999, an increase of 19% in culture positive cases was noted (63 cases).
The attendance has remained stable
over the last 7 years. Most women with vaginal discharge and vulval pruritus see
their primary care physician or Practice nurse either of who initiate referral.
Most magazines read by women similarly provide advice to patients to attend the
clinic, if symptoms of intractable vulval pruritus are discerned. This would
also account for the skewed sex ratio in favour of female noted amongst
attendants. In 1999 there were 266 cases.
The prevalence has remained low with
an initial fall and slight rise as shown in the graph in the annex. We have now
discontinued routine culture in women.
In 1998 there were 3 cases and 5
cases in 1999.
Although principally done in the Bure
Clinic, there are a number of other test sites in the district. The local drug
rehabilitation centres, the remand and prisons, the renal dialysis centre and
the infertility unit. These alternative sites follow the rigid pre and post test
counseling inherent in HIV antibody testing.
In the Bure Clinic in 1996
there were 222 HIV antibody tests carried out amongst 106 females age range 15 -
53 years and 116 males aged 19 - 65 years.
In 1997
there were 282 HIV antibody tests done on 135 females aged 15 - 66 years and 147
males aged 12 - 61 years.
In 1998
there were 380 HIV antibody tests carried out amongst 177 females aged 13-60
years and 203 males aged 15-74 years.
In 1999
there were 351 HIV antibody tests carried out amongst 177 females aged 14 – 55
and 174 males aged 16 – 61 years. Of the males 5 declared themselves
homosexual.
Total cohort of HIV positive patients
in 1999 was 20. The cumulative total incidence in our local population is
(0.016%) or 17 per 100,000 population amongst those aged 15 - 64.
The risk categories of the present
cohort are 32% homosexual/bisexual, 64% heterosexually acquired of which - 9.5%
acquired from sub-Saharan Africa, & Thailand, 4% intravenous drug use and a
combination of bisexuality and undetermined cause.
In 1995, 66 colposcopies were performed whereas in 1996 only 26 colposcopies were performed. In 1997 only 21 colposcopies were performed. This reduced numbers of colposcopy performed in 1996/97 was largely due to revised criteria for colposcopy following changes in National Guidelines.
In 1997/98, the reduced numbers is still reflective of the reduced threshold in colposcoping females with genital warts as a sole criterion. .
August 1999 saw the addition of a
second Health Advisor to the Bure Clinic team.
Although only part-time, Alison Jennings’ appointment has not only
allowed myself to attend regularly important planning and funding meetings such
as the HIV Prevention Working Group, but has also allowed the clinic to adopt a
new pro active model with regards to contact tracing and clinical home visiting
of our HIV positive clients. Previously,
community work and meeting attendance was limited due to the workload within the
clinic
FOR
GONORRHOEA AND CHLAMYDIA
|
|
|
|
|
|
Gonorrhoea |
|
|
Chlamydia |
|
The financial year of 1999/2000 has
had to see many areas within the National Health Service consolidate on earlier
achievements. Within the Bure
Clinic at the James Paget Healthcare NHS Trust, this task has been approached
with maturity and awareness that the attention of the public, media, politicians
and those commissioning services, remains concentrated on meeting more high
profile agendas. This is against
the continued background of life within a locality where sexual health continues
to deteriorate driven by the domination of an ever-increasing sexual culture. The focus for the organisation and local health systems on
emergency care/waiting lists/cancer continues to distract from the broader
service issues, which are essential to holistic care within a whole system
health economy.
The Multidisciplinary Team within the
Bure Clinic has continued to develop services and this has been enabled
throughout 1999/2000 by the additional 4 consultant sessions, resourced as a
result of the organization's ‘Star Chamber’ process and recognition of the
workload demands and deteriorating waiting lists previously experienced within
1998/99 and earlier. At the same
time, the support of Norfolk Health Authority in the funding of a part time
Health Advisor post has allowed the service to continue to develop themes of
innovative practice and individual patient support.
Both commitments are recognized as having been extremely positive in the
support of quality holistic care for the patient population served by the Bure
Clinic, however, it should also be noted that these same developments emphasize
an increase in workload on the nursing establishment within this area where
additional funding to support this service has not been obtained.
As with many smaller specialist
areas, the Medical Directorate has to continue in its efforts to ensure that
services such as those of Genito-Urinary Medicine are placed firmly on the
organisational and local health system agenda.
As processes mature, such as the development of local health improvement
plans, opportunities will arise to promote the necessity of what areas such as
the Bure Clinic can achieve given time, resource and support.
Concerns about local deterioration in sexual health have continued, and
remain as a significant challenge for those looking to halt their progress.
Whilst the developments that have occurred thus far mean that the service
has not been overwhelmed, it is certainly not possible to say that the service
is yet able to do more than defend its position and hold its ground, let alone
fight back.
Future emphasis, within 2000 / 2001,
on issues such as health education, positive promotion of sexual health and
broadening the awareness of the availability of Genito-Urinary Medicine
services, will help make up further lost ground in the future.
However, these are initiatives, which can only occur if a recurring
commitment is made to ensure that the developments of the last 12 months become
part of a strong foundation for local Genito-Urinary Medicine service provision
and not a fleeting response to a service-facing crisis.
The team from the Bure Clinic will continue to provide a quality service,
on behalf of their patient group, and on behalf of the many people within the
local health system who don’t yet recognize that they will be accessing these
services at some time, perhaps in the not too distant future!
Mr Andrew Fox, Medical Services Manager
The
last year has seen Dr. Sims join our team.
We are very happy to have him working with us, as no doubt are the
patients because we are now able to offer appointments on the same day or within
twenty-four hours in a working week. This
helps to achieve an optimum service.
We
have been unable to recruit a suitable Bank Nurse, after considerable effort!
Nurse and Secretarial hours were not increased in tandem with the
Clinical and Health Advising hours. I am still hoping that monies may be
forthcoming to enable us to advertise for extra establishment hours.
The
high level of teenage pregnancies causes particular concern.
I feel the way forward is education, or as our revered leader, Mr. Blair
would say, “Education, Education, Education.”
We
are looking at ways we can take the Genito-Urinary Medicine message out to the
Community, particularly to those at most risk.
A large gap has been left since Health Promotion moved from the James
Paget. We often got involved with
the team in promoting education sessions and open days etc. I feel that we must attempt to forge closer links with Health
Promotion in Norwich, but this is not as easy as having an accessible team in
this area.
Whilst
the National focus is centred on teenage pregnancies, we must not loose sight of
the very strong possibility of the transmission of infection in this group.
Therefore the work of the department in the diagnosing and treatment of
these infections, and the education, and Health Promotion that goes with this is
vitally important.
This
can only be achieved with an adequately staffed department, thus facilitating
easy access for the patient.
I
live in hope that this will be achieved.
Sue
Davies Sister in Charge
1.
Any persons presenting with a new clinical problem suggestive of a
sexually transmissible disease or who considers him/her self to have been in
contact with such a disease should be seen on the day of presentation or failing
that on the next occasion the clinic is open (This was recommended by the CMO in
his letter of 30th July 1986 to Regional General Managers)
2.
In accordance with the recommendation of the Monks report, arrangements
should be made for some evening clinic sessions to be held after 5pm
3.
Twenty minutes consultation for new patients recommended by the Royal
College of Physicians.
4.
Ensure adequate staffing level of Health Advisors to provide their
traditional role of contact tracing, partner notification, provider referral,
pre and post test counseling for HIV antibody test and opportunistic sexual
health education to all attendee and the community from sexual health promotion
activities with voluntary and statutory bodies.
5.
Regions should be required to review the distribution of their main GUM
services and make improvements where necessary
1.
Creation
of a middle-grade post
2.
Increase
additional nursing support.
3. Increase additional secretarial support.
|